Illini, O., Fabikan, H., Swalduz, A., Vikström, A., Krenbek, D., Schumacher, M., Dudnik, E., Studnicka, M., Öhman, R., Wurm, R., Wannesson, L., Peled, N., Kian, W., Bar, J., Daher, S., Addeo, A., Rotem, O., Pall, G., Zer, A., Saad, A., Cufer, T., Sorotsky, H. G., Hashemi, S. M. S., Mohorcic, K., Stoff, R., Rovitsky, Y., Keren-Rosenberg, S., Winder, T., Weinlinger, C., Valipour, A., & Hochmair, M. J. (2022). real-world experience with capmatinib in MET exon 14-mutated non-small cell lung cancer (RECAP): a retrospective analysis from an early access program. Therapeutic advances in medical oncology, 14, . http://access.bl.uk/ark:/81055/vdc_100169888349.0x0000de